beta blocker: be contraindicated in diabetes

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be contraindicated in diabetes 1.00
be contraindicated in diabetes mellitus 0.99
be contraindicated in disease 0.96
be contraindicated in asthma 0.95
be contraindicated with asthma 0.95
be contraindicated in copd 0.94
be contraindicated in patients with asthma 0.94
be contraindicated in in raynaud 0.94
be contraindicated in patients 0.94
be contraindicated in pregnancy 0.94

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.72
Similarity weight: 0.94
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.42
¬ Remarkable(atenolol, be contraindicated in pregnancy)
0.07
Rule weight: 0.13
Evidence weight: 0.57
Similarity weight: 0.95
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.65
¬ Remarkable(atenolol, be contraindicated in asthma)

Remarkability from sibling implausibility

0.53
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.95
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.65
Remarkable(atenolol, be contraindicated in asthma) ⋁
Evidence: 0.75
¬ Plausible(atenolol, be contraindicated in asthma)
0.51
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.94
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.42
Remarkable(atenolol, be contraindicated in pregnancy) ⋁
Evidence: 0.70
¬ Plausible(atenolol, be contraindicated in pregnancy)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.85
¬ Salient(beta blocker, be contraindicated in diabetes)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.99
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in diabetes mellitus)
0.73
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.44
¬ Typical(beta blocker, be contraindicated in in raynaud)
0.72
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.94
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.66
¬ Salient(beta blocker, be contraindicated in copd)
0.72
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.94
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.66
¬ Salient(beta blocker, be contraindicated in in raynaud)
0.72
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.94
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be contraindicated in copd)
0.71
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.95
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.79
¬ Salient(beta blocker, be contraindicated with asthma)
0.71
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.50
¬ Plausible(beta blocker, be contraindicated in in raynaud)
0.71
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.95
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.84
¬ Salient(beta blocker, be contraindicated in asthma)
0.71
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.99
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.81
¬ Typical(beta blocker, be contraindicated in diabetes mellitus)
0.70
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.78
¬ Salient(beta blocker, be contraindicated in pregnancy)
0.70
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.94
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.53
¬ Plausible(beta blocker, be contraindicated in copd)
0.70
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.95
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.67
¬ Typical(beta blocker, be contraindicated in asthma)
0.70
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.94
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.95
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.72
¬ Typical(beta blocker, be contraindicated with asthma)
0.69
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.99
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in diabetes mellitus)
0.68
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.74
¬ Typical(beta blocker, be contraindicated in pregnancy)
0.68
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.95
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.69
¬ Plausible(beta blocker, be contraindicated in asthma)
0.68
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.95
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.69
¬ Plausible(beta blocker, be contraindicated with asthma)
0.67
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.94
Evidence: 0.80
Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)
0.67
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.94
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.70
¬ Plausible(beta blocker, be contraindicated in pregnancy)
0.65
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.94
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.65
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.99
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated in diabetes mellitus)
0.63
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.94
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.63
¬ Remarkable(beta blocker, be contraindicated in pregnancy)
0.62
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.95
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated with asthma)
0.62
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.94
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.60
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.94
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.74
¬ Remarkable(beta blocker, be contraindicated in copd)
0.60
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.95
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.77
¬ Remarkable(beta blocker, be contraindicated in asthma)
0.59
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.94
Evidence: 0.66
Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.79
¬ Remarkable(beta blocker, be contraindicated in in raynaud)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.85
Salient(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.80
¬ Typical(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.76
Plausible(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.80
¬ Typical(beta blocker, be contraindicated in diabetes)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.48
Similarity weight: 0.95
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.79
¬ Typical(atenolol, be contraindicated in asthma)
0.06
Rule weight: 0.14
Evidence weight: 0.46
Similarity weight: 0.94
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes) ⋁
Evidence: 0.82
¬ Typical(atenolol, be contraindicated in pregnancy)